EMPRELVIA Trademark

Trademark Overview

On Tuesday, January 24, 2017, a trademark application was filed for EMPRELVIA with the United States Patent and Trademark Office. The USPTO has given the EMPRELVIA trademark a serial number of 87311927. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 31, 2020. This trademark is owned by Corbus Pharmaceuticals, Inc.. The EMPRELVIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of inflammatory and fibrotic diseases
emprelvia

General Information

Serial Number87311927
Word MarkEMPRELVIA
Filing DateTuesday, January 24, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 31, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of inflammatory and fibrotic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 28, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCorbus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorwood, MA 02062
Party NameCorbus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorwood, MA 02062

Trademark Events

Event DateEvent Description
Monday, August 31, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 31, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, January 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 30, 2020EXTENSION 5 GRANTED
Monday, January 27, 2020EXTENSION 5 FILED
Thursday, January 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 27, 2020TEAS EXTENSION RECEIVED
Wednesday, August 21, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 21, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2019EXTENSION 4 GRANTED
Thursday, July 25, 2019EXTENSION 4 FILED
Thursday, July 25, 2019TEAS EXTENSION RECEIVED
Friday, January 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 16, 2019EXTENSION 3 GRANTED
Wednesday, January 16, 2019EXTENSION 3 FILED
Wednesday, January 16, 2019TEAS EXTENSION RECEIVED
Saturday, July 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2018EXTENSION 2 GRANTED
Thursday, July 19, 2018EXTENSION 2 FILED
Thursday, July 19, 2018TEAS EXTENSION RECEIVED
Saturday, January 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2018EXTENSION 1 GRANTED
Thursday, January 18, 2018EXTENSION 1 FILED
Thursday, January 18, 2018TEAS EXTENSION RECEIVED
Tuesday, July 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2017ASSIGNED TO EXAMINER
Saturday, January 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

emprelvia fibrotic diseases inflammatory treatment products pharmaceutical